Derek M Meisner Acumen Pharmaceuticals, Inc. (ABOS) insider trading activity

Derek M Meisner is Chief Legal Officer & Corp Sec of Acumen Pharmaceuticals, Inc.. Currently has a direct ownership of 161,127 shares of ABOS, which is worth approximately $222,355. The most recent transaction as insider was on Jan 21, 2025, when has been sold 3,418 shares (Common Stock) at a price of $1.59 per share, resulting in proceeds of $5,434. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 161K

48.0% 3M change

48.0% 12M change

Total Value Held $222,355

Derek M Meisner Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Jan 21 2025	SELL Open market or private sale	$5,434 $1.59 p/Share	3,418 Reduced 2.08%	161,127 Common Stock
Jan 06 2025	BUY Grant, award, or other acquisition	-	66,800 Added 28.87%	164,545 Common Stock
Jan 03 2025	SELL Open market or private sale	$20,464 $1.84 p/Share	11,122 Reduced 10.22%	97,745 Common Stock
Jan 19 2024	SELL Open market or private sale	$31,086 $3.48 p/Share	8,933 Reduced 7.58%	108,867 Common Stock
Jan 02 2024	BUY Grant, award, or other acquisition	-	91,000 Added 43.58%	117,800 Common Stock
Jan 17 2023	BUY Grant, award, or other acquisition	-	26,800 Added 50.0%	26,800 Common Stock

Also insider at

XFOR

X4 Pharmaceuticals, Inc Healthcare

Chief Legal Officer

DMM

Derek M Meisner

Chief Legal Officer & Corp Sec

Boston, MA

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells ABOS shares.

Notify only if

Value

Insider Trading

Get notified when an Acumen Pharmaceuticals, Inc. insider buys or sells ABOS shares.

Notify only if

Operation

Value

Type

News

Receive news related to Acumen Pharmaceuticals, Inc.

Track Activities on ABOS

Account